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Enantioselective total synthesis of virosaine A and
bubbialidine†‡
Hideki Miyatake-Ondozabal, Linda M. Bannwart and Karl Gademann*
The first enantioselective total syntheses of virosaine A and bubbiali-
dine are described. Key transformations include the formation of a
tetracyclic intermediate via an intramolecular aza-Michael addition,
generation of aN-hydroxy-pyrrolidine through a Cope elimination and
an intramolecular [1,3]-dipolar cycloaddition to generate a complex
7-oxa-1-azabicyclo[3.2.1]octane ring system.
The securinega alkaloids are a family of bridged tetracyclic natural
products occurring in the plants of the Securinega, Phyllanthus,
Flueggea and other genera in the Euphorbiaceae family.1 Recently,
two new birdcage-shaped alkaloids with unprecedented skeletal
structures were isolated, namely virosaine A (1) and virosaine B (2),
from the twigs and leaves of Flueggea virosa (Fig. 1).2 The unique
structural features of these pseudoenantiomers are characterized
by their densely functionalized, stereochemically complex architec-
ture featuring an unusual tetracyclic core incorporating a trihydro-
1,2-oxazine ring. Neither 1 nor 2 showed cytotoxic activity against
selected cancer cell lines (MCF-7, MDA-MB-231, HepG2, HepG2/
ADM, HL-60, K562 and Hep2).2
Among this family of natural products, securinine (3) is the most
abundant and widely spread alkaloid possessing an impressive
range of biological activity including neurotransmitter gamma-
aminobutyric acid (GABA) receptor antagonism,3 in vivo CNS activity
and anti-malarial and anti-bacterial activities.4,5 Due to its remarkable
biological activities and intriguing molecular structure, numerous
total syntheses have been reported to date.1b,6 Conversely, a
related yet much rarer securinega alkaloid (+)-phyllantidine (4)
has a similar cyclic hydroxylamine scaﬀold to virosaines A (1)
and B (2) and only one total synthesis has been published due
to its complex architecture.7 During the preparation of this
manuscript, the first total synthesis of virosaine B was reported
by Yang, Li and coworkers.8 Two other putatively related
alkaloids bubbialidine (5) and bubbialine (6) were isolated
from the leaves of Zygogynum pauciflorum by Potier et al. in
1990.9 There is no reported publication for the synthesis of
virosaine A and bubbialidine to date. In this communication,
we report the first total syntheses of virosaine A (1) and
bubbialidine (5).
Our brief retrosynthetic analysis is illustrated in Scheme 1.
The main synthetic strategies are the vinylogous Mannich
reaction, an intramolecular aza-Michael addition, a late-stage
regioselective oxidation of the pyrrolidine moiety to the nitrone
and the subsequent intramolecular [1,3]-dipolar cycloaddition.
Inspired by the proposed biosynthesis of virosaines suggested by
Zhang, Ye and coworkers,2 we envisaged that nitrone 7 should
undergo a stereoselective intramolecular cycloaddition to form
the complex tetracyclic core 1, creating three new stereogenic
centres. A regioselective oxidation could be achieved in N-hydroxy-
pyrrolidine 8 leading to 7. Following a synthetic strategy described
by Magnus et al.,10 oxidation precursor 8 should be available
from tetracycle 9 through an N-oxidation–Cope elimination
sequence. An intramolecular aza-Michael addition of pyrrolidinyl-
furanone 10 would allow the formation of 9, which will serve as
a masked alkene intermediate enabling N-oxidation in the next
step. Finally, a vinylogous Mannich reaction between aminol 11
and furanone 12 should provide the key intermediate 10 after
t-butyloxycarbonyl (Boc) deprotection.
Fig. 1 Virosaines A, B and examples of related alkaloids.
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The preparation of silyl-protected aquilegiolide (+)-12 was
carried out following three reported publications (Schemes 2
and 3).11 The synthesis started with commercially available
1,4-cyclohexadiene 13. A three step procedure involving mono-
epoxidation, ring-opening with cyanomethyllithium and acetyla-
tion gave the racemic acetate ()-14 in 22% yield. Enzymatic
kinetic resolution was then employed to generate enantiomeri-
cally enriched alcohol ()-15 and acetate (+)-14 with 94.6% ee
and 96.0% ee, respectively.11a
Treatment of alcohol ()-15 under basic conditions triggered
the hydrolysis of the nitrile functionality (Scheme 3). Subsequent
acid catalysed lactonisation with p-toluenesulfonic acid gave
lactone ()-16 in 80% yield over two steps. Following phenyl-
selenation and oxidative elimination, butenolide ()-17 was
accessed in moderate yield.11b The silyl protected aquilegiolide
(+)-12 was obtained by diastereoselective epoxidation (dr = 5 : 1),
base-induced epoxide opening and silyl protection in good yields
over three steps.11c
The enantioselective synthesis of virosaine A (1) is described
in Scheme 4. The first key transformation, a vinylogous Mannich
reaction,12 between (+)-12 and aminol 1113 was achieved using
triisopropylsilyl triflate as a Lewis acid, an elegant methodology
reported by Busque´ and coworkers.11c This resulted in the formation
of solely two diastereoisomers (among the four possible) in
1 : 1 ratio in a yield of 90%. Pleasingly, the two isomers were
separable by column chromatography allowing clean isolation
of the desired adduct ()-18. The Boc group was smoothly
removed using a hydrogen chloride solution to give ()-19 in a
quantitative yield. To our surprise, the treatment of HCl salt
()-19 with potassium hydrogenphosphate at elevated tempera-
ture facilitated an intramolecular aza-Michael addition14 to
furnish the tetracycle ()-9 in a remarkable yield of 90%.
This transformation enabled eﬃcient formation of N-oxide
20 (supported by 1H-NMR characterization) in the next step
usingm-chloroperbenzoic acid and the alkene functionality was
Scheme 1 Retrosynthesis of virosaine A and bubbialidine.
Scheme 2 Enantioselective synthesis of ()-15 and (+)-14.
Scheme 3 Synthesis of butenolide 12.
Scheme 4 Enantioselective synthesis of virosaine A (1).
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revealed under slightly acidic conditions to yield N-hydroxy-
pyrrolidine ()-8 in 77% yield over two steps.15 The next step
was the construction of the nitrone unit 7 utilizing a convenient
and mild method developed by Mukaiyama and coworkers.16
Gratifyingly, the use of N-t-butylbenzenesulfinimidoyl chloride
2117 at 78 1C resulted in a complete regioselective formation of
nitrone 7 due to steric encumbrance and an immediate intra-
molecular [1,3]-dipolar cycloaddition15a,18,19 was observed. Finally,
the removal of silyl group was performed using tetrabutylammo-
nium fluoride to give virosaine A (1) in a good yield of 81% over two
steps. The synthetic virosaine A (1) displayed identical physical and
spectroscopic data to those reported in the literature.2 In addition,
the first synthesis of bubbialidine (5) was also accomplished by silyl
deprotection of tetracycle ()-9 to give the target natural product in
92% yield (Scheme 5). The synthetic sample displayed identical
physical and spectroscopic data to the reported values.9
In summary, we report the first enantioselective total syntheses
of virosaine A (1) and bubbialidine (5). The synthesis of virosaine
A was achieved in 18 steps whereas bubbialidine was synthesized
in 15 steps starting from readily available material. Our synthetic
strategy can be highlighted by the intramolecular aza-Michael
addition for the construction of the tetracycle ()-9, Cope-
elimination for a late-stage oxidation of the pyrrolidine unit,
and an intramolecular cycloaddition reaction to build the
7-oxa-1-azabicyclo[3.2.1]octane ring core. Further application
of this approach towards related natural products is currently
under investigation.
We thank the Latsis Foundation for support of this work
(National Latsis Prize 2011 to K.G.).
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Scheme 5 Enantioselective synthesis of bubbialidine (5).
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